Austria Fights Honey Fraud with DNA Tests, ImmVira Shows Promise Against Brain Cancer, Nanotechnology Targets Breast Cancer, New Blood Test Predicts Heart Disease, and more...

(0:10): Austria Launches DNA Tests to Combat Honey Fraud Amid Rising EU Adulteration Concerns(2:18): ImmVira's Oncolytic Virus Shows Promise Against Aggressive Brain Cancer in Early Trials(4:21): Revolutionary Nanotechnology Targets Triple-Negative Breast Cancer with Precision, Reducing Side Effects(6:30): New Blood Test Outperforms Cholesterol Checks in Predicting Heart Disease Risk(8:51): Abpro and Celltrion Reveal Promising Results for New HER2-Targeted Cancer Therapy at AACR 2025To subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Yen.com.gh